Results 1 to 10 of about 30,626 (259)

Mucormycosis in Paediatric Patients After Haematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. [PDF]

Mycoses
ABSTRACT Background Data on the epidemiology, diagnostic methods and evidence‐based recommended treatment methods for children with mucormycosis who have undergone Haematopoietic stem cell transplantation (HSCT) are limited. Objective Summarise past recommendations and the latest literature on the treatment of HSCT in children with mucorin infection ...
Lei Y, Zhang J, Han X, Liu X, Wang J.
europepmc   +2 more sources

Neem and Turmeric in the management of Covid Associated Mucormycosis (CAM) derived through network pharmacology

, 2023
Sutapa Datta, Indrani Sarkar, Gargi Sen, Arnab Sen   +3 more
openalex   +1 more source

Evidence of Possible Mucormycosis Coinfection, Detected by Plasma Mucorales PCR, in Patients with Proven or Probable Aspergillosis. [PDF]

Infect Chemother
Jang HM, Kim JY, Kim W, Jang CY, Seo H, Lim SY, Kim SH.   +6 more
europepmc   +1 more source

Impact of Anatomical Extent and Combined Surgical-Medical Therapy on Survival in Sinonasal and Rhino-Orbito-Cerebral Mucormycosis: A 14-Year Retrospective ENT Cohort. [PDF]

J Clin Med
Kozan G, Dedeoğlu S, Ayral M, Akdağ M.
europepmc   +1 more source

Role of Face Masks in the Rise of Mucormycosis Cases in India during the COVID-19 Pandemic

, 2021
S N Chandan
openalex   +1 more source

Recurrent gastrointestinal bleeding after bowel perforation surgery in immunocompetent patients: invasive gastrointestinal mucormycosis: a case report. [PDF]

BMC Infect Dis
Yang L, Chen SL.
europepmc   +1 more source

Bruton tyrosine kinase inhibitors and invasive aspergillosis and mucormycosis: a case report and multi-center exploratory retrospective study. [PDF]

ASM Case Rep
Bhaimia E, Russell D, Santos CAQ.
europepmc   +1 more source

Rhinocerebral Mucormycosis

Annals of Saudi Medicine, 1995
Z M, Abunijem, S, Al-Shohaib, L B, Morrow   +2 more
openaire   +2 more sources

Albumin orchestrates a natural host defence mechanism against mucormycosis. [PDF]

Nature
Pikoulas A, Morianos I, Nidris V, Hamdy R, Intze E, López-López Á, Moran-Garrido M, Muthu V, Halabalaki M, Papaioanou V, Papadovasilaki M, Kyrmizi I, Gu Y, Camunas-Alberca SM, Aerts R, Mercier T, Vanbiervliet Y, Cho SY, Spallone A, Jiang Y, Samonakis D, Kastritis E, Lax C, Tzardi M, Eliopoulos A, Georgila K, Carvalho A, Kurzai O, Rudramurthy SM, Elie C, Lanternier F, Petratos K, Garre V, Drakos E, Maertens J, Bruno VM, Kontoyiannis DP, Barbas C, Soliman SSM, Ibrahim AS, Chamilos G.   +40 more
europepmc   +1 more source

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection

, 2021
Jan Christoph Banck, Niklas Mueller, Sibylle C. Mellinghoff, Martin Thelen, Alessia Fraccaroli, Viktoria Blumenberg, Philipp Koehler, Wolfgang G. Kunz, Martina Rudelius, Florian Schrötzlmair, Marion Subklewe, Hans Schlößer, Johanna Tischer, Oliver A. Cornely, Lars H. Lindner, Michael von Bergwelt‐Baildon   +15 more
openalex   +1 more source